Key Points
- CEO Grigorios Siokas bought 51,315 shares of Cosmos Health on Nov 20 at $0.62 (about $31,815) — and had bought 61,614 shares on Nov 19 at $0.65 — bringing his total stake to 6,271,813 shares (≈$3.89M), a 0.82% increase in ownership.
- Cosmos Health reported EPS of ($0.17) for the quarter (missing the ($0.01) consensus) while posting $17.11M in revenue, and the company shows negative margins and return on equity with a market cap of about $23.7M.
- Analyst and institutional activity is mixed: the stock carries an average rating of "Sell" (Weiss reaffirmed a sell while one firm rates it a hold), and Citadel Advisors notably increased its position by 133% to 225,507 shares.
Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas acquired 51,315 shares of the company's stock in a transaction that occurred on Thursday, November 20th. The shares were acquired at an average price of $0.62 per share, with a total value of $31,815.30. Following the completion of the transaction, the chief executive officer owned 6,271,813 shares in the company, valued at $3,888,524.06. The trade was a 0.82% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Grigorios Siokas also recently made the following trade(s):
- On Wednesday, November 19th, Grigorios Siokas bought 61,614 shares of Cosmos Health stock. The stock was acquired at an average price of $0.65 per share, for a total transaction of $40,049.10.
Cosmos Health Price Performance
NASDAQ COSM traded up $0.05 during trading on Friday, hitting $0.68. 167,846 shares of the company's stock were exchanged, compared to its average volume of 430,412. The company has a market cap of $23.66 million, a PE ratio of -0.90 and a beta of 5.32. The company has a current ratio of 0.99, a quick ratio of 0.82 and a debt-to-equity ratio of 0.25. Cosmos Health Inc. has a fifty-two week low of $0.28 and a fifty-two week high of $1.32. The stock's 50 day moving average price is $0.93 and its two-hundred day moving average price is $0.71.
Cosmos Health (NASDAQ:COSM - Get Free Report) last announced its quarterly earnings results on Friday, November 14th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.16). The company had revenue of $17.11 million for the quarter, compared to the consensus estimate of $16.40 million. Cosmos Health had a negative net margin of 31.01% and a negative return on equity of 33.19%. Research analysts expect that Cosmos Health Inc. will post -0.78 EPS for the current year.
Analysts Set New Price Targets
A number of analysts have weighed in on COSM shares. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Cosmos Health in a research note on Wednesday, October 8th. Wall Street Zen upgraded Cosmos Health to a "hold" rating in a research report on Saturday, September 20th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has an average rating of "Sell".
Check Out Our Latest Report on Cosmos Health
Hedge Funds Weigh In On Cosmos Health
An institutional investor recently raised its position in Cosmos Health stock. Citadel Advisors LLC lifted its holdings in shares of Cosmos Health Inc. (NASDAQ:COSM - Free Report) by 133.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 225,507 shares of the company's stock after purchasing an additional 128,776 shares during the period. Citadel Advisors LLC owned 0.65% of Cosmos Health worth $250,000 as of its most recent filing with the SEC. Hedge funds and other institutional investors own 12.61% of the company's stock.
Cosmos Health Company Profile
(
Get Free Report)
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
